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Objective: To investigate the optimal combination of dietary polyphenols associated with the 
long-term risk of dementia in a large prospective French cohort of older persons, the Three-
City (3C) Study. 
Methods: We included 1,329 non-demented older adults from the 3C Study with assessment 
of intake of 26 polyphenol subclasses and followed for 12 years for dementia. Using Partial 
Least Square for Cox models, we identified a pattern of polyphenol intake associated with 
dementia risk. 
Results: The pattern combined several flavonoids (dihydroflavonols, anthocyanins, 
isoflavonoids, flavanones), stilbenes (including resveratrol), lignans and other subclasses 
(hydroxybenzaldehydes, naphtoquinones, furanocoumarins). Compared with participants in 
the lower quintile of pattern score, those in the higher quintile had a 50% lower risk of 
dementia (95% CI 20%; 68%, p-trend <0.01) in multivariate models.  
Conclusions: In this French cohort, a polyphenol pattern provided by a diet containing 
specific plant products (nuts, citrus, berries, leafy vegetables, soy, cereals, olive oil) 
accompanied with red wine and tea was associated with lower dementia risk.  
 





Polyphenols are a large family of phytochemical compounds (>500 species grouped into 5 
large classes: flavonoids, phenolic acids, stilbenes, lignans and other polyphenols)1 provided 
by various plant foods and beverages in the habitual diet. The cumulative intake of all dietary 
polyphenols may reach 1g/day, which is 10 to 100 times higher than the intake of most 
vitamins.1 
Polyphenols may constitute very promising targets for the prevention of cognitive aging and 
Alzheimer’s disease (AD). Some polyphenols (or their metabolites) can cross the blood brain 
barrier and may promote normal functioning and plasticity of the aging brain.2,3 Moreover, 
some polyphenol species (e.g., resveratrol, a stilbene provided by grape products) appear to 
exert anti-amyloid properties.4 
Epidemiological studies have reported associations of total flavonoids/polyphenols or of 
specific subclasses (e.g., anthocyanins) to: better memory;5 reduced cognitive decline;6,7 
lower risk of dementia;8 and higher odds of healthy aging.9 However, inconsistent findings 
have also been found.10–14 Cumulative exposures to multiple polyphenols, which may exert 
synergistic and/or complementary biological effects on the brain and may be more relevant 
than a single compound to prevent a disease with multiple pathological components such as 
AD,15 have been unexplored in relation to the risk of dementia. We thus conducted an 
exploratory study to examine whether a pattern of polyphenol intake (based on a weighted 
combination of 26 flavonoid and non-flavonoid subclasses) would be associated with the risk 
of dementia and AD over 12 years in a large prospective French cohort of older persons, the 






The 3C study is a French population-based cohort on dementia that started in 1999-2000, 
including 9,294 non-institutionalized community dwellers aged 65 years or older from three 
French cities:16 Bordeaux (n=2,104), Dijon (n=4,931) and Montpellier (n=2,259).  
At recruitment, participants provided sociodemographic, lifestyle and medical information, 
neuropsychological testing and blood sampling during in-person interviews. Follow-up 
examinations including repeated cognitive tests have been performed every 2 to 3 years. In 
2001-2002, a comprehensive dietary survey was conducted in the Bordeaux center, including 
a 24-hour recall administered during a face-to-face interview by trained dieticians. The 
present study was based on participants from the Bordeaux 3C sample who participated in 
both the screening procedure for dementia and the dietary survey (n=1,658, see flow chart in 
(Dryad, Figure 1)). Among them, we excluded (i) prevalent dementia cases (n=76), (ii) 
participants who were not re-examined after baseline (n=109), and (iii) participants with 
missing data for the main covariates (education and apolipoprotein E [ApoE] genotype) 
(n=144). Our study sample thus included 1,329 participants followed for up to 12 years after 
dietary assessment. 
 
Standard Protocol Approvals, Registrations, and Patient Consents 
The Consultative Committee for the Protection of Persons participating in Biomedical 
Research at Kremlin-Bicêtre University Hospital (Paris, France) approved the 3C study 




Diagnosis of Dementia 
Incident dementia was ascertained through a three-stage protocol. At each follow-up visit, 
participants were administered a battery of neuropsychological tests during home interviews 
conducted by a trained psychologist. Participants suspected of cognitive impairment were 
then examined by a neurologist to establish a clinical diagnosis of dementia. Finally, an 
independent committee of neurologists reviewed all potential cases of dementia to validate 
diagnosis of dementia according to the Diagnostic and Statistical Manual of Mental Disorders 
(Fourth Edition).17 Dementia cases were classified as probable or possible AD based on the 
National Institute of Neurological and Communicative Disorders and Stroke and the 
Alzheimer’s Disease and Related Disorders Association Alzheimer’s criteria.18 
 
Assessment of polyphenol intakes  
Nutrient and polyphenol intakes were ascertained through a 24-hour dietary recall.19 
Participants were invited to report all meals and beverages consumed the day prior the 
interview (excluding week-end meals) along with quantities of intake using a manual of 
portion size photographs. We estimated individual daily intakes in polyphenols as the sum of 
estimated intakes of each food/beverage multiplied by its polyphenol content using Phenol-
Explorer, the first comprehensive database on polyphenol content in foods (http://phenol-
explorer.eu).20,21 Here, we focused on intakes of 26 main polyphenol classes/subclasses. 
 
Other variables 
Sociodemographic and lifestyle information included age at baseline, sex, level of education, 
alcohol intake, tobacco consumption and regular physical activity (defined as practicing a 
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sport or an intensive leisure activity [e.g., hiking] ≥1hour per week or engaging in a more 
moderate activity [e.g., walking or household] ≥1hour per day). ApoE-ε4 genotype was 
defined as carrying at least one ε4 allele vs no ε4 allele. Cardiovascular risk factors included 
Body Mass Index (BMI, weight (kg) divided by height2 (m²)), history of cardiovascular 
diseases, hypertension (blood pressure ≥140/90 mmHg or treated), hypercholesterolemia 
(total cholesterol ≥6.2 mmol/L or treated) and diabetes (fasting glucose ≥7.2 mmol/L or 
treated). Moreover, the number of medications regularly consumed was used as a general 
indicator of comorbidities. High depressive symptomatology was assessed using the Center 
for Epidemiological Studies-Depression (CES-D) scale.22 
 
Statistical analyses 
Identification of a pattern of polyphenol intake associated with the long-term risk of 
dementia 
We used Partial Least Square regression for Cox models (PLS-Cox)23 to investigate whether a 
specific pattern of polyphenol intake was associated with the risk of incident dementia over 
the 12 years following ascertainment of diet. PLS-Cox belongs to PLS regression methods24 –
a family of dimension reduction approaches (such as Principal Component Analysis [PCA]) 
which aims to extract summary components of a set of p predictors X that best explain the 
variability in a set of q outcomes Y (see (Dryad, Appendix)); PLS-Cox is an extension of 
PLS method for time-to-event data.23 We adapted the original PLS-Cox algorithm to allow 
covariate adjustment in the construction of the components. 
In the present analyses, the predictors X were the standardized intakes of 26 polyphenol 
subclasses and the response variable Y was the age of onset of dementia. As indicated by a 
five-fold cross-validation, we retained the first PLS-Cox component only (interpreted as a 
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pattern of polyphenol intake oriented toward the association with incident dementia). PLS 
components can be interpreted using their Pearson correlations with the original X; in this 
study, we primarily considered polyphenol subclasses with an absolute correlation with the 
component score ≥0.25. 
 
Multivariate associations between the pattern of polyphenol intake and the risk of dementia 
We used Cox proportional hazards models with delayed entry and age as time scale to 
evaluate the multivariate associations between quintiles of the polyphenol pattern score and 
the risk of dementia, adjusting for potential confounders. First, we controlled for the variables 
used in PLS-Cox (sex, education, ApoE-ε4, total energy intake and season of the 24h recall; 
model 1). We further adjusted for lifestyle factors, cardiovascular and health-related risk 
factors and other nutrients (vitamins C, D, and E, carotene, folate, long-chain omega 3 fatty-
acids and saturated fats) (model 2). We examined linear trends across quintiles of polyphenol 
pattern by using median values of each quintile as a continuous variable. We secondarily 
analyzed AD specifically. Moreover, we investigated the interaction of the polyphenol pattern 
score with ApoE-ε4 genotype on incident dementia/AD. 
To limit exclusions due to missing values, we only excluded participants with missing values 
for the main potential confounders (model 1). For other covariates, data were missing for <3% 
of the sample, we thus assigned to missing data the reference category (for categorical 
variables) or the median value (for continuous variables), except for regular exercise that was 
missing for 11.8% of the sample and for which we created a specific missing category. In all 
Cox models, the proportional hazards and the log-linearity assumptions were satisfied. 
Statistical analyses were performed using SAS software version 9.3 and the R software 
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We conducted sensitivity analyses to assess the robustness of our findings to potential reverse 
causation (which occurs when incipient dementia modifies dietary habits) by: (1) further 
adjusting the models for global cognitive performance at baseline, represented by the Mini 
Mental State Examination (MMSE) score;25 (2) excluding participants with baseline 
MMSE<26 and those who developed dementia within the 5 years following dietary 
assessment. 
In addition, we investigated the foods most contributive of our polyphenol pattern; we 
described average intakes of top food contributors across quintiles of the pattern score, and we 
computed the correlation between these foods and the pattern score. 
 
Data availability 
Additional material can be accessed via the Dryad Digital Repository: 






Characteristics of the sample 
The 1,329 study participants were 75.8 years old on average at baseline. A total of 256 
participants were diagnosed with dementia, including 169 AD cases, during a median follow-
up of 11.7 years (range 0.9-13.1 years). 
Compared to participants who remained free of dementia over the follow-up, those who 
developed the disease were older at baseline (Table 1); they were also more likely to be 
ApoE-ε4 carrier and diabetics, and they consumed more medications.  
On average, participants consumed a total of 1,071 mg/day of polyphenols at baseline (Table 
2); with higher total intakes reported in men compared to women (see (Dryad, Table 1) for 
average absolute and energy-adjusted polyphenol intakes stratified by sex). Intakes of the 
large polyphenol classes at baseline did not differ significantly between participants 
diagnosed with dementia and those who remained free of dementia (Table 2; see (Dryad, 
Table 2) for energy-adjusted polyphenol intakes), although future dementia cases tended to 
have slightly lower intakes in all 5 main classes of polyphenols. Likewise, none of the 26 
polyphenol subclasses were significantly associated with the risk of dementia when 
considered individually (results not shown in tables). 
 
Pattern of polyphenol intake associated with the risk of dementia  
When we combined the 26 subclasses of polyphenols using PLS-Cox, we found a pattern of 
polyphenol intake strongly associated with a lower risk of dementia (see Figure 1 for 
cumulative risk of dementia by quintiles of the polyphenol pattern score).  
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The pattern score was associated with higher intakes of hydroxybenzaldehydes, 
dihydroflavonols, stilbenes and lignans (all correlations >0.50; Table 3); other important 
contributors to the pattern (with correlations between 0.25 and 0.40) included 
naphtoquinones, anthocyanins, isoflavonoids, flavanones and furanocoumarins (see Table 4 
for average polyphenol intakes and (Dryad, Table 3) for baseline characteristics across 
quintiles of score).  
In multivariate analyses, the polyphenol pattern score remained associated with a lower risk 
of dementia (p for trend <0.007 in model 2; Table 5). The score was also associated with a 
lower risk of AD (p for trend=0.047 in model 2). For example, compared with participants in 
the lower quintile of score, those in the higher quintile had a 50% lower risk of dementia over 
12 years (95% CI=20% to 68%), and a 48% lower risk of AD (95% CI=7% to 71%). These 
associations were not modified by ApoE-ε4 status.  
 
Supplementary analyses 
In sensitivity analyses, associations were virtually unchanged when we further adjusted for 
baseline cognition; likewise, findings were not modified when we excluded the n=163 
participants with MMSE<26 at baseline, or the n=65 participants diagnosed with dementia 
within the first five years of follow-up, suggesting that reverse causation was not likely to 
explain our findings. 
We secondarily investigated the top dietary sources of the pattern of polyphenol intake. In this 
cohort from South West of France, red wine was an important source of polyphenols, 
including those most representative of our pattern, i.e., hydroxybenzaldehydes, 
dihydroflavonols, stilbenes, lignans and anthocyanins (for which red wine contributed to 40 to 
100% of the intakes, Figure 2A; correlation of red wine intake with the PLS-Cox 
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component=0.66; Figure 2B). Other important contributors were nuts, soy products, citrus 
fruits, leafy vegetables, olive oil and berries (Figure 2 A and B). Accordingly, for those top 
contributors there was a strong gradient of increasing intakes across quintiles of the pattern 
score (Table 4). For example, participants in the higher quintile of score reported daily 
consumptions equivalent to: 2.5 standard glasses (125 mL) of red wine; 1 cup of tea; half a 
handful of nuts (or 5 walnuts); 1 small orange and 4 strawberries; 1.5 medium stalks of celery; 






In this large cohort of older persons, we identified a pattern of polyphenol intake associated 
with a decreased risk of all-cause dementia and of AD over 12 years. Compared with 
participants in the lower quintile of the polyphenol pattern score, those in the higher quintile 
had an approximately 50% lower risk of both dementia and AD, independently of major 
potential confounders. The pattern was mostly characterized by 9 polyphenol subclasses 
including specific flavonoids (dihydroflavanols, anthocyanins, isoflavonoids and flavanones), 
stilbenes (including resveratrol), lignans and additional isolated polyphenols 
(hydroxybenzaldehydes, naphtoquinones and furanocoumarins). It was associated with a diet 
rich in specific plant products including nuts, citrus and berries, leafy vegetables, soy products 
and cereals, accompanied with red wine and tea and regular consumption of olive oil.  
 
The few epidemiological studies which have investigated polyphenol intakes in relation to 
cognitive aging or dementia yielded conflicting results. Primary results from the PAQUID 
cohort showed an association between total flavonoid intake and a lower risk of dementia and 
cognitive decline over 10 years.7,8 These findings were replicated in the large Nurses’ Health 
Study;6 yet no association was found either with the risk of dementia or AD in the Rotterdam 
study,10,11 or with cognitive decline in both the Zutphen Elderly and The Invecchiare in 
Chianti studies.12,13 Likewise, cohorts which examined total flavonoid/polyphenol intakes in 
midlife in relation to cognition or dementia risk in older ages found inconsistent results.5,14 
Total polyphenol intake was significantly associated with better global cognitive performance 
at baseline in our cohort (results not shown in the manuscript and available upon request), yet 
it was not associated with a lower incidence of dementia. Total polyphenol intake is 
determined by the polyphenol species most consumed in the diet rather than the species 
biologically linked to brain health, and thus, it may incompletely reflect brain-protective 
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polyphenol exposures. The strong relationship between a polyphenol pattern and dementia 
risk (yet no significant association with either individual subclasses or total polyphenol 
intake) found here suggests that combining specific polyphenols may be more relevant for 
brain health than a simple addition of polyphenols in the diet.  
 
Our polyphenol pattern partly reflects plant-based healthy diets which have been previously 
associated with a lower risk of dementia outcomes. For example, the Mediterranean diet 
(MeDi), which combines several polyphenol-rich components, has been associated with lower 
risk of AD,27 and with preserved global cognition in persons at high vascular risk in a large 
trial.28 Interestingly, our findings showing associations of polyphenol subclasses to dementia 
only when combined in a pattern are similar to what previously reported with the MeDi (with 
individual components inconsistently related to dementia outcomes in studies unless 
combined in a global pattern score).27 Most foods represented in our polyphenol pattern are 
also found in the MIND (Mediterranean-dietary approach to stop hypertension Intervention 
for Neurodegenerative Delay) diet, which was associated with slower cognitive decline and 
lower risk of AD in the Rush Memory and Aging Project.29 Thus overall, the results obtained 
here through a statistical learning approach, without formulating any a priori hypothesis, 
reinforces these previous associations found with several plant-based dietary scores. 
 
Most of the polyphenols constituting our pattern have documented clinical effects in cognitive 
aging and AD. For example, in moderately-sized trials (N<150), moderate to high doses of 
resveratrol (ie, 200-2000 mg/day) increased hippocampal connectivity and memory in older 
adults, 30,31 and decreased plasma and cerebrospinal fluid amyloid-β levels in AD patients.32 
Moreover, a few small trials demonstrated efficacy of flavanols in increasing hippocampal 
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vascular plasticity,33 and of both citrus flavanones and soy isoflavonoids in improving 
cognition in older persons.34,35 Moreover, it is plausible that the combination of polyphenols 
within foods/beverages (e.g., grape products) or the overall diet may exert additive and/or 
synergistic effects on brain health. Indeed, the bioavailability of polyphenols, which is 
relatively restricted, depends on the polyphenol matrix present in the gut. For example, 
phenolic compounds (from blueberries) are more efficiently absorbed when consumed with a 
grape product.36 In addition, polyphenols may be involved in complementary neuroprotective 
pathways. For instance, catechin (a flavanol) and resveratrol display complementary 
neuroprotective effects against amyloid-induced toxicity in vitro.37 Overall, interactions 
between various polyphenols in the food matrix are still largely unknown and deserve further 
investigation. 
 
Our study is limited by the availability of a single 24h recall to assess polyphenol intake. A 
reported single day of intake may not fully capture individual variations in dietary habits and 
might lead to misclassifications. However, when sample size is sufficiently large, a single 24h 
recall can be used to assess average intakes in subgroups of a population.38 Accordingly, in 
our sample, estimated average intakes of the main polyphenol classes were very similar to 
those reported in another large French population-based cohort (the SU.VI.MAX study21) 
based on several 24h records, which certainly supports the validity of our estimations. 
Moreover, using a single 24h recall, we found expected associations of several nutrients/diet 
patterns with brain aging outcomes in our previous research.39,40 Besides, our findings based 
on an older population from the French Bordeaux area with specific cultural habits (including 
a regular consumption of red wine) might not be generalizable to populations with other 
dietary habits.  
17 
 
Our study has also major strengths, including use of the most comprehensive polyphenol 
database to date, a longitudinal population-based design with more than a decade of follow-up 
and a clinical diagnosis of dementia validated by an independent committee of neurologists. 
The long lag period between the dietary survey and the diagnosis of dementia and sensitivity 
analyses suggested that reverse causation is unlikely to explain our results. Finally, we were 
able to control for a large set of potential confounders, including other antioxidants and 
healthy nutrients (although we cannot exclude that residual confounding still persists). 
 
In this large cohort of French older persons, we identified a pattern of polyphenol intake 
reflecting a diet providing specific plant products including nuts, certain fruits (berries and 
citrus) and leafy vegetables, soy products and cereals, accompanied with red wine and tea and 
regular consumption of olive oil, strongly associated with a lower risk of both dementia and 
AD. The weighted combination of polyphenols evidenced in this exploratory study deserves 
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Table 1. Baseline characteristics of the participants according to incident all-cause 
dementia over 12 years, the 3C Bordeaux cohort (N=1,329). 







Age (years) 75.8 (4.8) 78.1 (4.6) 75.3 (4.7) <.001 
Sex, female 62.1 69.9 60.2 0.56 
Education, ≥ high school 40.9 35.2 42.2 0.07 
ApoE-ε4 carrier 18.3 22.3 17.3 0.003 
Alcohol consumption 
categories 
   0.12 
0 g/day 19.3 16.9 19.9  
≤12 g/day 44.6 51.6 42.9  
]12-24] g/day 18.7 19.7 18.5  
>24 g/day 17.4 11.8 18.7  
Tobacco consumption 
categories 
   0.84 
0 pack-year 64.6 70.2 63.3  
<10 pack-years 12.0 10.7 12.3  
[10-20[ pack-years 6.4 6.3 6.4  
[20-30[ pack-years 5.4 3.6 5.9  
≥ 30 pack-years 11.5 9.1 12.1  
Regular exercise 35.5 31.0 36.5 0.62 
BMI (kg/m²) 26.6 (4.1) 26.2 (4.4) 26.6 (4.1) 0.42 
Hypercholesterolemia 57.8 63.7 56.4 0.14 
Diabetes 9.5 15.2 8.1 <.001 
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History of cardiovascular 
diseases 
32.4 30.5 32.8 0.45 
Hypertension 75.5 77.6 75.0 0.77 
High depressive 
symptomatology 
7.5 10.7 6.7 0.13 
Number of drugs 
consumed 
4.8 (2.9) 5.6 (3.2) 4.6 (2.8) <.001 
Values are mean (standard deviation) or percentages (of non-missing values). 
a Univariate Cox Proportional Hazards models with delayed entry and age as time scale 
(except for age which use a standard Cox Proportional Hazards model). 
Abbreviations: ApoE-ε4, allele ε4 for the apolipoprotein E gene; BMI, Body Mass Index.  
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Table 2. Average intakes of total polyphenol and of the main classes of polyphenols at 
study baseline according to incident all-cause dementia over 12 years, the 3C Bordeaux 
cohort (N=1,329). 








Total polyphenols 1071 (570) 1029 (542) 1081 (576) 0.52 
Flavonoids 500 (353) 472 (304) 506 (363) 0.43 
Phenolic acids 546 (396) 534 (414) 549 (392) 0.87 
Stilbenes 4.46 (5.59) 3.80 (4.52) 4.62 (5.81) 0.27 
Lignans 0.38 (0.27) 0.35 (0.25) 0.38 (0.27) 0.45 
Other polyphenols 20 (18) 19 (16) 21 (18) 0.70 
Values are mean (standard deviation). Intakes are expressed in milligrams per day. 
a Univariate Cox Proportional Hazards models with delayed entry and age as time scale  
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Table 3. Correlation coefficients of the 26 polyphenol subclasses with the pattern of 
polyphenol intake associated with a reduced risk of dementia with Partial Least Square 
for Cox modela, the 3C Bordeaux cohort (N=1,329). 











Phenolic acids  
Hydroxybenzoic acids 0.21 
Hydroxyphenylacetic acids 0.15 
Hydroxycinnamic acids -0.01 
Hydroxyphenylpropanoic acids -0.23 
Stilbenes 0.65b 
Lignans 0.51b 
Other polyphenols  
Hydroxybenzaldehydes 0.68b 





Other polyphenols 0.05 





Hydroxycoumarins  -0.24 
Polyphenol subclasses are classified within the 5 main classes of polyphenols by descending 
correlation with the PLS-Cox component. 
a The PLS-Cox included adjustment of univariate relationships between each individual 
polyphenol and incident dementia for age, sex, level of education, ApoE-ε4, total energy 
intake and season of the 24h recall. 
b Polyphenol subclasses with an absolute Pearson correlation ≥0.25 with the PLS-Cox 
component were primarily considered for interpretation of the pattern.  
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Table 4. Average intakes of polyphenol subclasses representative of the pattern of 
polyphenol intake associated with a reduced risk of dementia and of top food sources 
across quintiles of pattern score, the 3C Bordeaux cohort (N=1,329). 
 
Quintiles of polyphenol pattern score 
Q1 Q2 Q3 Q4 Q5 
Polyphenol subclasses 
(mg/day) 
     
Hydroxybenzaldehydes 0.26 (0.45) 0.23 (0.41) 0.56 (0.53) 1.29 (0.78) 2.51 (1.43) 
Dihydroflavonols 1.7 (3.3) 1.4 (3.0) 3.9 (4.0) 9.4 (6.0) 18.1 (11.0) 
Stilbenes 1.2 (2.1) 1.0 (1.9) 2.6 (2.5) 6.0 (3.7) 11.5 (7.0) 
Lignans 0.22 (0.18) 0.26 (0.17) 0.32 (0.21) 0.46 (0.26) 0.62 (0.27) 
Naphtoquinones  0.01 (0.11) 0.0 (0.07) 0.02 (0.21) 0.06 (0.42) 0.91 (2.57) 
Anthocyanins 17.6 (45.7) 22.6 (45.7) 45.6 (75.5) 66.7 (91.1) 117.0 (123.2) 
Isoflavonoids  0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.19 (2.21) 3.65 (20.18) 
Flavanones 4.8 (15.2) 9.0 (23.8) 20.7 (30.5) 31.9 (42.2) 41.0 (51.8) 
Furanocoumarins 0.0 (0.01) 0.01 (0.08) 0.01 (0.08) 0.01 (0.07) 0.12 (0.83) 
Top food sources (g/day)      
Red wine 30 (60) 26 (54) 72 (73) 173 (110) 333 (203) 
Nuts 0.2 (2.2) 0.9 (5.6) 0.6 (4.7) 1.6 (8.6) 11.4 (30.3) 
Soy products 0 (0) 0 (0) 0.1 (1.2) 0.9 (12.0) 5.4 (30.0) 
Citrus 15 (48) 28 (71) 57 (79) 78 (102) 91 (122) 
Leafy vegetables 52 (84) 55 (81) 60 (93) 65 (108) 83 (135) 
Olive oil 1.0 (3.3) 1.9 (4.7) 2.1 (5.2) 2.6 (6.3) 2.4 (5.6) 
Berries 14 (53) 36 (99) 33 (88) 35 (91) 46 (117) 
Tea and infusion 77 (177) 136 (207) 138 (262) 112 (206) 115 (243) 
27 
 
Cereals 156 (111) 155 (105) 150 (100) 178 (108) 174 (99) 




Table 5. Multivariate associations between the polyphenol pattern score obtained by 
PLS-Cox and the risk of all-cause dementia and Alzheimer’s disease over 12 years, the 
3C Bordeaux cohort (N=1,329).  
 
Incident all-cause dementia Incident Alzheimer’s Disease 
Model 1 Model 2 Model 1 Model 2 
Pattern score     
Quintile 1 1.0 (reference) 1.0 (reference) 1.0 (reference) 1.0 (reference) 
Quintile 2 0.73 (0.50-1.06) 0.71 (0.49-1.04) 0.79 (0.50-1.24) 0.76 (0.48-1.22) 
Quintile 3 0.73 (0.50-1.05) 0.64 (0.43-0.95) 0.75 (0.47-1.19) 0.67 (0.41-1.10) 
Quintile 4 0.72 (0.49-1.05) 0.65 (0.43-0.97) 0.81 (0.50-1.29) 0.75 (0.46-1.23) 
Quintile 5 0.57 (0.37-0.86) 0.50 (0.32-0.80) 0.54 (0.32-0.93) 0.52 (0.29-0.93) 
p for trend 0.016 0.007 0.045 0.047 
Values are HR (95% CI) for Cox Proportional Hazards models with delayed entry using age 
as time-scale.  
Model 1: adjusted for sex, level of education, ApoE-ε4, total energy intake and season of the 
24h recall. 
Model 2: covariates from model 1 plus alcohol and tobacco consumptions, regular exercise, 
Body Mass Index, hypercholesterolemia, diabetes, history of cardiovascular diseases, 
hypertension, depressive symptomatology and number of drugs consumed, intakes of 





Figure 1. Kaplan-Meier curves for the cumulative risk of incident all-cause dementia by 
quintiles of the polyphenol pattern score identified by PLS-Cox (quintile 1, dotted line; 
quintile 3, solid line; quintile 5, dashed line) 
 
Figure 2. Top food sources of the pattern of polyphenol intake associated with a reduced 
risk of dementia, the 3C Bordeaux cohort (N=1,329).  
 
A) Top food sources for the polyphenol subclasses representative of the pattern of polyphenol 
intake (i.e., subclasses with an absolute Pearson correlation ≥0.25 with the PLS-Cox 
component score). Polyphenol subclasses are classified in descending order for their 
correlation on the x axis. 
B) Pearson correlation coefficients of the candidate food contributors (i.e., top food sources of 
the polyphenol subclasses representative of the polyphenol pattern) with the PLS-Cox 
component score. 
